• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. No Sign of Slowdown in Biotech M&A

    High levels of merger and acquisition activity will be the big theme of year for biotech, says Morningstar's Lauren Migliore.

  2. A New Wide-Moat Find for European Investors

    This European-listed firm's employee lunch voucher program enjoys a dominant competitive position and benefits from a strong network effect.

  3. Our Top Five Biotech Acquisition Candidates

    M&A activity grew in 2010, and we expect deal volume to remain strong in 2011.

  4. Gen-Probe: New Tests Key to Increasing Revenue

    Gen-Probe's Michael Watts sees five potential new product launches as delivering top-line growth next year.

1
blog comments powered by Disqus
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.